Bryant Reid Tours The Lowance Center For Human Immunology At Emory

Bryant Reid, The Reid Foundation For Lupus Chair, met with Dr. Ignacio Sanz, Emory Division of Rheumatology Director, and Dr. Frances Lee, Emory Department of Medicine Associate Professor at The Lowance Center for Human Immunology.

The purpose of the Lowance Center for Human Immunology is to understand the immunological and molecular mechanisms responsible for human autoimmune, inflammatory, and allergic diseases. The Lowance Center studies both the innate and adaptive arms of the immune response and the mutual regulation of the two components.

According to the Mayo Clinic, lupus is a disease that occurs when your body’s immune system attacks your own tissues and organs (autoimmune disease). Inflammation caused by lupus can affect many different body systems — including your joints, skin, kidneys, blood cells, brain, heart, and lungs. It most often affects people of color, African American, Hispanic, and Asian people.

The importance of the Lowance Center’s research in advancing the understanding of lupus is obvious. The purpose of Mr. Reid’s tour was to provide him with a more in-depth understanding of the scope of work at the Lowance Center and to discuss possible ways The Reid Foundation for Lupus could support or enhance their work.

Dr. Sanz and Dr. Lee provided Mr. Reid with fundamental insights into the depth and scope of lupus research at the Lowance Center. The high ethical standards and transparency of the research at the Center were apparent throughout the tour.
Mentioned was the outstanding work performed by the faculty and in particular Dr. Sam Lim, The Reid Foundation For Lupus Board Member, Drs; Khosroshahi and Williams. Despite its excellent reputation, the Lowrance Center still struggles to find participants to assist them in the research required to understand — or cure –the disease.

The Reid Foundation for Lupus could be an invaluable partner in assisting the Lowance Center in encouraging communities of color to participate in their lupus research studies.

Mr. Reid felt the tour was an important step in building a working relationship between The Reid Foundation for Lupus and other institutions at the forefront of finding effective treatments and, ultimately, a cure for lupus.

READ MORE
Nation

Roberto Duran Supports The Reid Foundation For Lupus

Congratulations to Roberto Duran on his storied hall-of-fame career. He held the world championships in lightweight, welterweight, light middleweight, and middleweight classes.
Ring magazine voted him as the fifth greatest fighter of the last 80 years. He was also voted the best lightweight of the 20th century by the Associated Press.

The Reid Foundation for Lupus truly appreciates the support and is confident that with hard work and support from people like yourself, we can make a big difference.

READ MORE
News

Clinical Trial for New Lupus Treatment Opens in China

JW Therapeutics has received approval from the National Medical Products Administration of China to conduct a Phase 1 / 2 clinical trial of its CAR T-cell therapy, relmacabtagene autoleucel (relma-cel), for people with moderate to severe and/or treatment-resistant lupus. CAR T-cells are genetically altered T-cells that play a role in the immune response. Scientists create or engineer new cells called chimeric antigen receptors (CARs), and then introduce T-cells into them to create CAR-T cells.

 

READ FULL ARTICLE

 

Article Credit: Lupus Foundation of America | lupus.org

READ MORE
News

LUPKYNIS Continues to Show Promising Lupus Nephritis Outcomes

The drug treatment, LUPKYNIS® (voclosporin), reduced inflammation and prevented development of kidney damage in people with lupus nephritis (LN, lupus-related kidney disease) over 18 months. Those taking the medication also didn’t exhibit any signs of kidney-related toxicity. LUPKYINS® is a novel, structurally modified calcineurin inhibitor (CNI) that works in two ways – acting as an immunosuppressant through inhibition of T-cell activation and cytokine production, and by promoting podocyte stability in the kidney.

 

READ FULL ARTICLE

 

Article Credit: Lupus Foundation of America | lupus.org

READ MORE
  • 1
  • 2